Tag: vaccines

‘Twindemic’ test: Massachusetts, many colleges mandate winter flu shots

Protesters have swarmed downtown Boston and the state Capitol in the seven weeks since Republican Gov. Charlie Baker issued the first-of-its-kind requirement for students from preschool through college.As the Massachusetts mandate plays out, other states have weighed similar requirements while colleges throughout the country pile on their own orders to prevent flu patients from clogging doctors offices and emergency rooms alongside people infected with coronavirus this winter.

State laws across the country already require various vaccines for students and health care workers, while allowing a host of exemptions. Governments still have broad authority to implement new flu shot orders, potentially paving the way for mandatory inoculation against the coronavirus in a country where vaccine skepticismis spreading and President Donald Trump has resisted many public health protocols during the pandemic.

“This is a brave new experiment by the state of Massachusetts,” said Lawrence Gostin, who heads a university-based center on health law that serves as an official collaborating institute with the World Health Organization. “If it turns out to be a wholesale success, that should influence other states to go a similar route, not just with flu but with other vaccines. But if it causes a backlash and only marginal benefit, states might be hesitant to adopt that model in the future.”

Keep reading

Vaccine suppliers given indemnity for ‘inevitable’ side effects

The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against liability for rare side effects that experts say are “inevitable” when a vaccine is rolled out.

But the government will not set up a statutory compensation scheme, which the president of the Australian Medical Association, Omar Khorshid, said meant Australians who suffered “extremely rare” side effects from the vaccines would face a tough battle to seek compensation.

Keep reading

Operation Warp Speed Is Using A CIA-Linked Contractor To Keep Covid-19 Vaccine Contracts Secret

$6 billion in Covid-19 vaccine contracts awarded by Operation Warp Speed have been doled out by a secretive government contractor with deep ties to the CIA and DHS, escaping regulatory scrutiny and beyond the reach of FOIA requests.

Last Tuesday, while most Americans were distracted by the first US presidential debate, NPR quietly reported that the US government’s Operation Warp Speed, a public-private partnership launched by the Trump administration to rapidly develop and distribute a Covid-19 vaccine, had taken the unusual step of awarding contracts to vaccine companies, not directly, but through a secretive defense contractor.

Though NPR named thedefense contractor—South Carolina–based Advanced Technology International—they declined to explore the company’s deep ties to the CIA, Department of Homeland Security, and the Department of Defense and how ATI is helping to lead those agencies’ efforts to militarize health care and create a surveillance panopticon that not only monitors the world around us but our physiology as well.

The “secret” vaccine contracts awarded through ATI as part of Warp Speed total approximately $6 billion, accounting for the majority of Operation Warp Speed’s $10 billion budget. Both Paul Mango, Health and Human Services’ deputy chief of staff for policy, and Robert Kadlec, HHS assistant secretary for preparedness and response (ASPR), personally signed off on the contracts.

Operation Warp Speed, which officially involves the combined efforts of HHS and the military to deliver over 300 million Covid-19 vaccines to Americans by next January, is a highly secretive program dominated by military personnel, most of whom have no experience in health care or vaccine production. The Trump administration has often compared Warp Speed to the Manhattan Project, which produced the atomic bomb.

Several very unsettling revelations about the true nature and scope of Warp Speed, including the out-sized role of ATI, began to emerge starting last Monday. Yet, most of this new information was not covered by US news outlets due to the media frenzy surrounding the first presidential debate and the subsequent news that President Trump and several other politicians and White House officials had tested positive for Covid-19.

Keep reading

COVID-19 vaccine trial participants report aches, fevers and chills

Some participants for leading COVID-19 vaccine trials have reported experiencing grueling side effects after receiving the shot — such as high fever, body aches, headaches and exhaustion.

Five participants — three in Moderna’s study and two in Pfizer’s late-stage trials — said the uncomfortable side effects usually went away within a day, but some were surprised by how severe they were, CNBC reported.

“If this proves to work, people are going to have to toughen up,” one of the Moderna participants, a North Carolina woman in her 50s who declined to be identified, told the outlet.

“The first dose is no big deal. And then the second dose will definitely put you down for the day for sure. … You will need to take a day off after the second dose.”

She said she didn’t experience a fever but had a bad migraine that left her exhausted and struggling to focus, the outlet reported. But the next day, she woke up feeling better after taking Excedrin.

While she was uncomfortable, the side effects outweigh the risks of becoming infected with the virus, she said.

Keep reading

Engineering Contagion: UPMC, Corona-Thrax And “The Darkest Winter”

The recently obtained documents reveal that the BSL-3 lab that is part of UPMC’s Center for Vaccine Research is conducting eyebrow-raising research involving combining SARS-CoV-2 with Bacillus anthracis, the causative agent of anthrax infection. Per the documents, anthrax is being genetically engineered by a researcher, whose name was redacted in the release, so that it will express the SARS-CoV-2 spike protein, which is the part of the coronavirus that allows it to gain access into human cells. The researcher asserts that “the [genetically engineered anthrax/SARS-CoV-2 hybrid] can [be] used as a host strain to make SARS-CoV-2 recombinant S protein vaccine,” and the creation of said vaccine is the officially stated purpose of the research project. The documents were produced by the University of Pittsburgh’s Institutional Biosafety Committee (IBC), which held an emergency meeting on June 22nd of this year to “discuss specific protocols involving research with the coronavirus,” which included a vote on the aforementioned proposal.

Keep reading

Covid-19 origins, the Wuhan lab, US funding, and vaccine connection

Starting in 2014, the National Institutes of Health granted millions of dollars in U.S. tax money to a “global environmental health nonprofit” called EcoHealth Alliance based in New York City.

The grant was for an eleven-year-long project entitled: “Understanding the risk of bat coronavirus emergence.” It aimed to study coronavirus in bats in China to determine which strains had the greatest risk of spillover to humans. (In other words, in hopes of preventing something like the Covid-19 pandemic and/or providing quick mitigation.)

A total of  $3,748,715 was given for the project from 2014-2019.

EcoHealth Alliance’s partners on the taxpayer-funded project included scientist at China’s Wuhan Institute of Virology.

The Chinese researchers at the Wuhan Institute of Virology also “received assistance from the Galveston National Laboratory at the University of Texas Medical Branch and other U.S. organizations.”

The Wuhan Institute of Virology is located in the area of China where scientists believe the Covid-19 outbreak originated. Investigators have not ruled out the possibility that the virus was somehow released from the lab, either by accident or intentionally.

Keep reading